Drugs / Tenofovir/Emtricitabine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01332227 | Oct 2011 → Sep 2013 | — | Bristol-Myers Squibb | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tenofovir/Emtricitabine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01332227 ↗ |
| Route | Oral | “Tablets, Oral, 300/200 mg, Once daily, 48 weeks” NCT01332227 ↗ |